Barlow’s Syndrome Market Research Report- Forecast to 2027

Barlow’s Syndrome market research report: by type (mitral valve stenosis), treatment (medication and surgical treatment), diagnosis (X-Ray, and Echocardiogram), end-users (hospitals & surgical centers, and specialty clinics) – Global forecast till 2027

ID: MRFR/MED/4147-HCR | February 2021 | Region: Global | 105 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario:


Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shifts towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.


Barlow’s Syndrome can be caused by various reasons, some of them are calcium buildup, congenital heart defects, radiation treatment, and tumors. Additionally, traumatic injury, disease, or infection can lead to Barlow’s Syndrome.


The global Barlow’s Syndrome market is estimated to lead a healthy growth. The global Barlow’s Syndrome market is majorly driven by increasing geriatric population, rising global population, and rising cardiovascular disorders. According to a report published by the U.S. Population Reference Bureau, nearly 46 million people aged 65 years or more in 2014, and the report estimates that this number would double to reach nearly 98 million people by the end of 2060. Similarly, the 65-and-older age group would reach  up to nearly 24% by 2030 from 15% as of 2015.


Global Barlow’s Syndrome market is expected to grow at a CAGR of 9% during the forecast period.


Figure: Global Barlow’s Syndrome market, by region, 2017 (%)


 Barlow’s Syndrome


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation


 Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology:


 Barlow’s Syndrome 1


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation


Segments  


The global Barlow’s Syndrome market is segmented on the basis of type, treatment, diagnosis, and end-users.


On the basis of the type, the market is segmented as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.


On the basis of the treatment, the market is segmented into medications and surgery. The medications are further sub-segmented into beta-blockers and calcium blockers. Beta-blockers further sub-segmented into Atenolol and Metoprolol. Calcium blockers further sub-segmented into Verapamil and Diltiazem.  


On the basis of the diagnosis, the market is segmented into X-ray, Electrocardiogram, and Echocardiogram.


On the basis of the end user, the market is segmented into hospitals & surgical centers, research institutes, and specialty clinics.


Regional Analysis


North America holds the maximum share of the global Barlow’s Syndrome market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing geriatric population, rising number of cardiovascular disorders, and growing population have increased the scope of the Barlow’s Syndrome   market in the North American market.


Europe holds  the second largest share of the global Barlow’s Syndrome   market. The European market is expected to grow at a healthy growth during the forecasted period. Various Factors such as availability of advanced treatment facilities, increasing cardiovascular diseases, and skilled medical professionals  are propelling the growth of Barlow’s Syndrome  market in the European region. For instance, according to the European Heart Network, cardiovascular disorders accounted for 45% of the total deaths in 2015. Additionally, increasing government healthcare initiatives and growing research and development activities supported by the government to provide better healthcare treatments are likely to boost the market growth.  


The Asia Pacific is expected to be the fastest growing market owing to increasing incidence of chronic diseases, and fetal disorders. India is the fastest growing region owing to increasing population and increasing geriatric population. Rising awareness, growing standard of living, and availability of new treatment methods are likely to drive the market growth in this region.


The Middle East & Africa is expected to show steady growth in the market . Major factors that are affecting the growth are lack of awareness, and  limited access and availability of treatment facilities. In the Middle East, United Arab Emirates  has accounted for the largest market share owing to the development of healthcare infrastructure, skilled healthcare providers.


Key Players       


Some of the key players in the barlows syndrome market are Abbott, Medtronic, CryoLife, Inc., Lepu Medical Technology Co., Ltd. Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, and JenaValve Technology, Inc



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9% (2018-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, Diagnosis, and End-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott, Medtronic, CryoLife, Inc., Lepu Medical Technology Co., Ltd. Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, and JenaValve Technology, Inc
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing geriatric population
  • Rising global population
  • Rising cardiovascular disorders


  • Frequently Asked Questions (FAQ) :


    Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shift towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.

    The market is expected to exhibit a strong 9% CAGR over the forecast period from 2017 to 2023.

    The increasing geriatric population is a major driver for the Barlow’s Syndrome Market.

    The Americas hold the largest share in the Global Barlow’s Syndrome Market.

    Leading players in the Barlow’s syndrome market include Abbott, Medtronic, and CryoLife, among others.

    Table Of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Barlow’s Syndrome Market, By Type

    6.1 Introduction

    6.2 Mitral Valve Stenosis

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Mitral Valve Prolapse

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Mitral Valve Regurgitation

    6.4.1 Market Estimates & Forecast, 2020-2027

    7. Global Barlow’s Syndrome Market, By Treatment

    7.1 Introduction

    7.2 Medication

    7.2.1 Beta-Blockers

    7.2.1.1 Atenolol

    7.2.1.2 Metoprolol

    7.2.1.3 Propranolol

    7.2.2 Calcium Blockers

    7.2.2.1 Verapamil

    7.2.22 Diltiazem

    7.2.3 Market Estimates & Forecast, 2020-2027

    7.3 Surgery

    7.3.1 Market Estimates & Forecast, 2020-2027

    8. Global Barlow’s Syndrome Market, By Diagnosis

    8.1 Introduction

    8.2 X-Ray

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Electrocardiogram

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Echocardiogram

    8.4.1 Market Estimates & Forecast, 2020-2027

    9. Global Barlow’s Syndrome Market, By End User

    9.1 Introduction

    9.2 Hospitals & Surgical Centers

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Research Institutes

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Specialty Clinics

    8.4.1 Market Estimates & Forecast, 2020-2027

    9 Global Barlow’s Syndrome Market, By Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 U.K.

    9.3.1.4 Italy

    9.3.1.5 Spain

    9.3.1.6 Rest Of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic Of Korea

    9.4.6 Rest Of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest Of The Middle East & Africa

    10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    11 Company Profiles

    11.1 Abbott Laboratories, Inc.,

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Biotronik Pvt Ltd

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Colibri Heart Valve

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Edward Lifesciences

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 HLT Medical

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial Overview

    11.5.4 Key Developments

    11.6 Medtronic Plc

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 LivaNova Plc

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs Of The Market

    12.2 Key Companies To Watch

    12.3 Prediction Of Pharmaceutical Industry

    13 Appendix

    LIST OF TABLES

    Table 1 Barlow’s Syndrome Industry Synopsis, 2020-2027

    Table 2 Global Barlow’s Syndrome Market Estimates And Forecast, 2020-2027, (USD Million)

    Table 3 Global Barlow’s Syndrome Market By Region, 2020-2027, (USD Million)

    Table 5 Global Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 6 Global Barlow’s Syndrome Market By Diagnosis, 2020-2027, (USD Million)

    Table 7 Global Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 8 North America Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 9 North America Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 10 North America Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 11 US Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 12 US Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 13 US Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 14 Canada Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 15 Canada Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 16 Canada Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 17 South America Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 18 South America Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 19 South America Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 20 Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 21 Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 22 Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 23 Western Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 24 Western Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 25 Western Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 26 Eastern Europe Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 27 Eastern Europe Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 28 Eastern Europe Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 29 Asia Pacific Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 30 Asia Pacific Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 31 Asia Pacific Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Barlow’s Syndrome Market By Treatment, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Barlow’s Syndrome Market By Daignosis, 2020-2027, (USD Million)

    Table 34 Middle East & Africa Barlow’s Syndrome Market By End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Global Barlow’s Syndrome Market

    Figure 3 Segmentation Market Dynamics For Barlow’s Syndrome Market

    Figure 4 Global Barlow’s Syndrome Market Share, By Treatment 2020

    Figure 5 Global Barlow’s Syndrome Market Share, By Diagnosis 2020

    Figure 6 Global Barlow’s Syndrome Market Share, By End Users, 2020

    Figure 7 Global Barlow’s Syndrome Market Share, By Region, 2020

    Figure 8 North America Barlow’s Syndrome Market Share, By Country, 2020

    Figure 9 Europe Barlow’s Syndrome Market Share, By Country, 2020

    Figure 10 Asia Pacific Barlow’s Syndrome Market Share, By Country, 2020

    Figure 11 Middle East & Africa Barlow’s Syndrome Market Share, By Country, 2020

    Figure 12 Global Barlow’s Syndrome Market: Company Share Analysis, 2020 (%)

    Figure 13 Abbott Laboratories, Inc: Key Financials

    Figure 14 Abbott Laboratories, Inc: Segmental Revenue

    Figure 16 Abbott Laboratories, Inc: Geographical Revenue

    Figure 17 Biotronik Pvt Ltd: Key Financials

    Figure 18 Biotronik Pvt Ltd: Segmental Revenue

    Figure 19 Biotronik Pvt Ltd: Geographical Revenue

    Figure 20 Colibri Heart Valve: Key Financials

    Figure 21 Colibri Heart Valve: Segmental Revenue

    Figure 22 Colibri Heart Valve Geographical Revenue

    Figure 23 Edward Lifesciences: Key Financials

    Figure 24 Edward Lifesciences: Segmental Revenue

    Figure 25 Edward Lifesciences: Geographical Revenue

    Figure 26 HLT Medical: Key Financials

    Figure 27 HLT Medical: Segmental Revenue

    Figure 28 HLT Medical: Geographical Revenue

    Figure 29 LivaNova Plc: Key Financials

    Figure 30 LivaNova Plc: Segmental Revenue

    Figure 31 LivaNova Plc: Geographical Revenue

    Figure 32 Medtronic. Key Financials

    Figure 33 Medtronic. Segmental Revenue

    Figure 34 Medtronic. Geographical Revenue